患者对肥胖治疗风险的看法：一项创新的健康倡议——肥胖表型分层以优化未来肥胖治疗（IMI2 SOPHIA）定性研究。
Patient perspectives on the risks of obesity treatment: An innovative health initiative stratification of obesity phenotypes to optimise future obesity therapy (IMI2 SOPHIA) qualitative study.
作者信息
Farrell Emma, Nadglowski Joseph, Hollmann Eva, le Roux Carel W, McGillicuddy Deirdre
机构信息
University College Dublin, Dublin, Ireland.
Obesity Action Coalition, Tampa, FL, USA.
出版信息
Obes Pillars. 2024 Aug 23;12:100129. doi: 10.1016/j.obpill.2024.100129. eCollection 2024 Dec.
BACKGROUND
The uptake of obesity treatments remains disproportionally low in people living with the disease, even with the advent and availability of GLP-1 agonists in recent years. Efforts to understand this discrepancy have centred on literature syntheses and Healthcare Professionals' (HCPs) perspectives on the barriers to obesity treatment. This study focuses on patient perspectives on the of obesity treatment.
METHOD
This qualitative study consisted of online focus groups with 30 adults with obesity from Europe and North America. The focus group discussions were recorded, transcribed verbatim and analysed thematically.
RESULTS
Patients identified three risks associated with obesity treatment: (a) the risk that they can't access treatment; (b) the risk that they would fail to meet treatment expectations - their own, their HCPs and societal expectations, and (c) the risk that the treatment would be 'successful' but that they would lose their sense of self, their coping mechanisms and identity along with weight.
CONCLUSION
Understanding patient concerns about the risks of obesity treatment is essential to addressing obesity treatment inertia.
背景
尽管近年来胰高血糖素样肽-1（GLP-1）激动剂问世且可获取，但肥胖症患者对肥胖治疗的接受程度仍然极低。为理解这一差异所做的努力主要集中在文献综述以及医疗保健专业人员（HCPs）对肥胖治疗障碍的看法上。本研究聚焦于患者对肥胖治疗的看法。
方法
这项定性研究由与来自欧洲和北美的30名成年肥胖者进行的在线焦点小组组成。焦点小组讨论进行了录音，逐字转录并进行了主题分析。
结果
患者确定了与肥胖治疗相关的三种风险：（a）无法获得治疗的风险；（b）未能达到治疗期望的风险——他们自己的、其医疗保健专业人员的以及社会期望，以及（c）治疗“成功”但他们会随着体重减轻而失去自我意识、应对机制和身份认同的风险。
结论
了解患者对肥胖治疗风险的担忧对于解决肥胖治疗惰性至关重要。
Zotero 插件